Related Experiment Video
Updated: Jun 16, 2026
10:05
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
Published on: November 13, 2015
[Construction and characterization of cardiac specific promoter-driven expression vector]
Wenjun He1, Shichong Li, Lingling Ye
1Department of Cell Engineering, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|February 2, 2010
Summary
Researchers created a novel cardiac-specific expression vector using the alpha-myosin heavy chain (alpha-MHC) promoter. This vector, alpha-MHC-EGFP, specifically targets cardiomyocytes for gene expression and purification.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Gene Expression
Context:
- Developing targeted gene delivery systems is crucial for studying and treating cardiac diseases.
- Existing vectors often lack specificity, leading to off-target effects.
- The alpha-myosin heavy chain (alpha-MHC) gene is a well-established marker for differentiated cardiomyocytes.
Purpose:
- To construct and validate a novel cardiac-specific gene expression vector.
- To ensure the vector drives expression exclusively in cardiomyocytes.
- To assess the vector's utility in isolating specific cardiac cell populations.
Summary:
- A cardiac-specific expression vector, alpha-MHC-EGFP, was successfully constructed by replacing the CMV promoter with the alpha-MHC promoter.
- PCR amplification and cloning techniques were employed to generate the alpha-MHC promoter fragment.
- Transfection into mouse primary cardiomyocytes via electroporation demonstrated specific green fluorescence, confirming cardiomyocyte-targeted expression.
Impact:
- This vector provides a valuable tool for studying cardiomyocyte function and cardiac development.
- It enables the purification of embryonic stem cell-derived cardiomyocytes for research and therapeutic applications.
- Facilitates advancements in regenerative medicine and the understanding of cardiac biology.
